The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,370.00
Bid: 12,370.00
Ask: 12,374.00
Change: 38.00 (0.31%)
Spread: 4.00 (0.032%)
Open: 12,350.00
High: 12,432.00
Low: 12,314.00
Prev. Close: 12,332.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS SUMMARY: S&P CapIQ Cuts Next To Buy From Strong Buy

Tue, 05th Jan 2016 09:43

LONDON (Alliance News) - The following shares received analyst recommendations Tuesday morning:
----------
FTSE 100
----------
S&P CAPITAL IQ CUTS NEXT TO 'BUY' ('STRONG BUY') - TARGET 85 (91) PENCE
----------
CREDIT SUISSE RAISES BUNZL PRICE TARGET TO 1780 (1660) PENCE - 'NEUTRAL'
----------
CREDIT SUISSE RAISES TRAVIS PERKINS TO 'OUTPERFORM' ('NEUTRAL') - TARGET 2255 (1838) PENCE
----------
Deutsche Bank Upgrades Tesco To Buy From Hold Ups Price Target To 210p From 200p
----------
JPMORGAN RAISES HIKMA PRICE TARGET TO 2700 (2500) PENCE - OVERWEIGHT
----------
JPMORGAN RAISES GLAXOSMITHKLINE PRICE TARGET TO 1390 (1370) PENCE - 'NEUTRAL'
----------
JPMORGAN RAISES ASTRAZENECA PRICE TARGET TO 4500 (4400) PENCE - 'NEUTRAL'
----------
Cantor Fitzgerald Raises Royal Mail To Buy From Hold Ups Price Target To 530p From 500p
----------
BARCLAYS CUTS ABERDEEN AM TO UNDERWEIGHT (EQUAL WEIGHT) - TARGET 250 (350) PENCE
----------
SOCGEN CUTS MARKS & SPENCER PRICE TARGET TO 595 (652) PENCE - 'BUY'
----------
JPMORGAN RAISES SMITH & NEPHEW PRICE TARGET TO 1089 (1024) PENCE - 'NEUTRAL'
----------
FTSE 250
----------
MORGAN STANLEY CUTS SSP GROUP TO 'UNDERWEIGHT' ('EQUAL-WEIGHT')
----------
HSBC INITIATES JLT GROUP WITH 'BUY' - TARGET 1020 PENCE
----------
JPMORGAN CUTS ROTORK PRICE TARGET TO 170 (180) PENCE - 'NEUTRAL'
----------
JPMORGAN CUTS HALFORDS GROUP PRICE TARGET TO 380 (460) PENCE - 'NEUTRAL'
----------
JPMORGAN RAISES BODYCOTE PRICE TARGET TO 510 (500) PENCE - 'UNDERWEIGHT'
----------
JPMORGAN CUTS BTG TO 'NEUTRAL' ('OVERWEIGHT') - TARGET 780 (900) PENCE
----------
GOLDMAN CUTS MELROSE INDUSTRIES PRICE TARGET TO 360 (380) PENCE - 'BUY'
----------
BARCLAYS RAISES LANCASHIRE HOLDINGS PRICE TARGET TO 428 (419) PENCE - UNDERWEIGHT
----------
BARCLAYS RAISES HISCOX PRICE TARGET TO 684 (645) PENCE - 'UNDERWEIGHT'
----------
GOLDMAN CUTS WEIR GROUP PRICE TARGET TO 1500 (1550) PENCE - 'BUY'
----------
GOLDMAN CUTS SPECTRIS PRICE TARGET TO 2130 (2200) PENCE - 'BUY'
----------
Deutsche Upgrades Morrisons To Hold From Sell, Price Target 155p
----------
MAIN MARKET AND AIM
----------
JPMORGAN CUTS OXFORD INSTRUMENTS PRICE TARGET TO 870 (950) PENCE - 'OVERWEIGHT'
----------
GOLDMAN CUTS OXFORD INSTRUMENTS PRICE TARGET TO 685 (700) PENCE - 'NEUTRAL'
----------
JPMORGAN RAISES SPIRE HEALTHCARE PRICE TARGET TO 395 (310) PENCE - 'NEUTRAL'
----------
JPMORGAN RAISES CAMBIAN PRICE TARGET TO 278 (222) PENCE - 'OVERWEIGHT'
----------
JPMORGAN RAISES ABCAM PRICE TARGET TO 606 (558) PENCE - 'NEUTRAL'
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2016 Alliance News Limited. All Rights Reserved.

More News
8 May 2024 19:10

Sector movers: Aerospace and Defence, Pharma pace gains

(Sharecast News) - London's main stock market gauges continued to push higher in the middle of the week, even as investors waited on the Bank of England's policy announcement on the following day.

Read more
8 May 2024 17:46

FTSE 100 hits record high, pound slips ahead of BoE verdict

FTSE 100 up 0.5%, FTSE 250 adds 0.4%

*

Read more
8 May 2024 16:36

London close: Stocks rise further ahead of BoE decision

(Sharecast News) - London's stock markets closed with gains on Wednesday, bolstered by a dip in the value of the pound against both the dollar and the euro.

Read more
8 May 2024 09:44

AstraZeneca says withdraws Covid vaccine "for commercial reasons"

(Alliance News) - Drugmaker AstraZeneca PLC said Wednesday that it has withdrawn its Covid vaccine Vaxzevria, one of the first produced in the pandemic, citing "commercial reasons" and a surplus of updated jabs.

Read more
8 May 2024 09:39

LONDON BROKER RATINGS: UBS raises Centrica to 'buy' from 'neutral

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
7 May 2024 15:54

Berenberg hikes target price on Astrazeneca

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker Astrazeneca from 1,200.0p to 1,300.0p on Tuesday, citing the group was "instilling confidence in the revenues of tomorrow".

Read more
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.